
NMRA P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.52
Average-0.4960
Median-0.4600
Minimum-0.6800
Maximum-0.4200
-0.52
Past Month-0.11 (26.83%)
The P/E ratio for NMRA is -0.52 as of Jun 13, 2025. This represents a decrease of -85.56% compared to its 12-month average P/E ratio of -3.6. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Neumora Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Neumora Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Neumora Therapeutics Inc to industry peers.
Neumora Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Neumora Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Neumora Therapeutics Inc to industry peers.
NMRA P/E Ratio Insights
See Neumora Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NMRA
Order type
Buy in
Order amount
Est. shares
0 shares
NMRA P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $0.7479 | -0.46 |
May 1, 2025 | $0.7714 | -0.51 |
Apr 1, 2025 | $0.9133 | -0.60 |
Mar 3, 2025 | $1.405 | -0.92 |
Feb 3, 2025 | $1.86 | -1.01 |
Jan 2, 2025 | $1.97 | -1.07 |
NMRA End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.52 | -90.94% |
2024 | -5.74 | -65.65% |
2023 | -16.71 | — |
FAQs About Neumora Therapeutics Inc (NMRA) P/E ratio
The latest P/E ratio of NMRA is -0.52, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Neumora Therapeutics Inc’s last 12-month average P/E ratio is -3.6, compared to its current P/E ratio of -0.52. This reflects a decrease of -85.56%.
Neumora Therapeutics Inc’s current P/E ratio of -0.52 is lower than its last 12-month average P/E of -3.6. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Neumora Therapeutics Inc’s average P/E ratio over the last 3 years is -4.15. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Neumora Therapeutics Inc’s average P/E ratio over the last 5 years is -2.49. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.